March 8, 2012
/PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Barclays Capital Global Healthcare Conference
Wednesday, March 14, 2012
11:15 a.m. ET
8:15 a.m. PT
, M.D., vice president, medical research and development at Amylin Pharmaceuticals, will provide a corporate overview.
The presentation will be webcast through the "Investors" section of Amylin's corporate website at
, and a recording will be made available following the event. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin is committed to delivering novel therapies that transform the way diabetes and other metabolic disorders are treated. Amylin is headquartered in
San Diego, Calif.
and has a commercial manufacturing facility in
. More information about Amylin Pharmaceuticals is available at
SOURCE Amylin Pharmaceuticals, Inc.